Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106

References

1. Apt D., Chong T., Liu Y., Bernard H. U. 1993; Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol 67:4455–4463
   [Google Scholar]
2. Astori G., Arzese A., Pipan C., de Villiers E. M., Botta G. A. 1997; Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res 50:57–63 [CrossRef]
   [Google Scholar]
3. Castle P. E., Schiffman M., Gravitt P., Kendall H., Fishman S., Hildesheim A., Herrero R., Bratti M. C., Sherman M. other authors 2002; Evaluation of HPV DNA detection by PCR. J Med Virol 68:417–423 [CrossRef]
   [Google Scholar]
4. Chan W. K., Chong T., Bernard H. U., Klock G. 1990; Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res 18:763–769 [CrossRef]
   [Google Scholar]
5. Chen Z., Schiffman M., Herrero R., Desalle R., Burk R. D. 2007; Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology 360:447–453 [CrossRef]
   [Google Scholar]
6. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F. 2005; Carcinogenicity of human papillomaviruses. Lancet Oncol 6:204 [CrossRef]
   [Google Scholar]
7. de Villiers E. M., Fauquet C., Broker T. R., Bernard H. U., zur Hausen H. 2004; Classification of papillomaviruses. Virology 324:17–27 [CrossRef]
   [Google Scholar]
8. Dong X. P., Stubenrauch F., Beyer-Finkler E., Pfister H. 1994; Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 58:803–808 [CrossRef]
   [Google Scholar]
9. Forslund O., Antonsson A., Nordin P., Stenquist B., Hansson B. G. 1999; A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 80:2437–2443
   [Google Scholar]
10. Gloss B., Bernard H. U. 1990; The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol 64:5577–5584
    [Google Scholar]
11. Herrero R., Castle P. E., Schiffman M., Bratti M. C., Hildesheim A., Morales J., Alfaro M., Sherman M. E., Wacholder S. other authors 2005; Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796–1807 [CrossRef]
    [Google Scholar]
12. Huelsenbeck J. P., Ronquist F. 2001; mrbayes: Bayesian inference of phylogenetic trees. Bioinformatics 17:754–755 [CrossRef]
    [Google Scholar]
13. Ishiji T., Lace M. J., Parkkinen S., Anderson R. D., Haugen T. H., Cripe T. P., Xiao J. H., Davidson I., Chambon P., Turek L. P. 1992; Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J 11:2271–2281
    [Google Scholar]
14. Moscicki A. B., Schiffman M., Kjaer S., Villa L. L. 2006; Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 24 (Suppl. 3):S42–S51
    [Google Scholar]
15. Narechania A., Chen Z., Desalle R., Burk R. D. 2005; Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol 79:15503–15510 [CrossRef]
    [Google Scholar]
16. Schiffman M., Herrero R., Desalle R., Hildesheim A., Wacholder S., Rodriguez A. C., Bratti M. C., Sherman M. E., Morales J. other authors 2005; The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337:76–84 [CrossRef]
    [Google Scholar]
17. Swofford D. L. 1998 paup*. Phylogenetic Analysis Using Parsimony (*and other methods) Sunderland, MA: Sinauer;
    [Google Scholar]
18. Terai M., Burk R. D. 2001; Complete nucleotide sequence and analysis of a novel human papillomavirus (HPV 84) genome cloned by an overlapping PCR method. Virology 279:109–115 [CrossRef]
    [Google Scholar]
19. Terai M., Burk R. D. 2002; Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89, candHPV90, and candHPV91. J Infect Dis 185:1794–1797 [CrossRef]
    [Google Scholar]
20. Thompson J. D., Gibson T. J., Plewniak F., Jeanmougin F., Higgins D. G. 1997; The clustal_x windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882 [CrossRef]
    [Google Scholar]